Erschienen in:
14.01.2021 | Original Research
Project ACTIVE: a Randomized Controlled Trial of Personalized and Patient-Centered Preventive Care in an Urban Safety-Net Setting
verfasst von:
Melanie Applegate, DNP, RN, FNP-BC, Ebony Scott, MSEd, MHC, Glen B. Taksler, PhD, Mirtala Sanchez, MPH, Nguyet Duong, MSN, ANP-BC, Laurie Mark, MSN, FNP-BC, Ellen Caniglia, ScD, Andrew Wallach, MD, R. Scott Braithwaite, MD, MSc
Erschienen in:
Journal of General Internal Medicine
|
Ausgabe 3/2021
Einloggen, um Zugang zu erhalten
Abstract
Background
Evidence-based preventive care in the USA is underutilized, diminishing population health and worsening health disparities. We developed Project ACTIVE, a program to improve adherence with preventive care goals through personalized and patient-centered care.
Objective
To determine whether Project ACTIVE improved utilization of preventive care and/or estimated life expectancy compared to usual care.
Design: Single-site randomized controlled trial.
Participants
Cluster-randomized 140 English or Spanish speaking adult patients in primary care with at least one of twelve unfulfilled preventive care goals based on USPSTF grade A and B recommendations.
Intervention
Project ACTIVE employs a validated mathematical model to predict and rank individualized estimates of health benefit that would arise from improved adherence to different preventive care guidelines. Clinical staff engaged the participant in a shared medical decision-making (SMD) process to identify highest priority unfulfilled clinical goals, and health coaching staff engaged the participant to develop and monitor action steps to reach those goals.
Main Measures
Change in number of unfulfilled preventive care goals from USPSTF grade A and B recommendations and change in overall gain in estimated life expectancy.
Key Results
In an intent-to-treat analysis, Project ACTIVE increased the average number of fulfilled preventive care goals out of 12 by 0.68 in the intervention arm compared with 0.15 in the control arm (mean difference [95% CI] 0.53 [0.19–0.86]), yielding a gain in estimated life expectancy of 8.8 months (3.8, 14.2). In a per-protocol analysis, Project ACTIVE increased fulfilled preventive care goals by 0.80 in the intervention arm compared with 0.16 in the control arm (mean difference [95% CI], 0.65 [0.25–1.04]), yielding a gain in estimated life expectancy of 13.7 months (6.2, 21.2). Among the 12 preventive care goals, more improvement occurred for alcohol use, hypertension, hyperlipidemia, depression, and smoking.
Conclusions
Project ACTIVE improved unfulfilled preventive care goals and improved estimated life expectancy.
Clinical Trial Registration Number
NCT04211883